{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:36:51Z","timestamp":1778891811114,"version":"3.51.4"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"913","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Amyloidosis is not a single disease but a series of diseases in which there is extracellular deposition of a protein which, although it may be derived from different and unrelated sources, folds into a \u03b2 pleated sheet.<\/jats:p>\n               <jats:p>There have recently been significant advances in elucidating the pathogenesis and in the treatment of this group of disorders. By identifying the source of precursor protein, treatment is aimed at eliminating or reducing the extent of deposition and is tailored for each patient.<\/jats:p>\n               <jats:p>Early diagnosis is required for the optimal effect of treatment on patient survival and quality of life. An increased awareness among physicians of the spectrum of the disease and tools to aid its diagnosis is of increasing importance.<\/jats:p>","DOI":"10.1136\/pmj.77.913.686","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:32:19Z","timestamp":1027765939000},"page":"686-693","source":"Crossref","is-referenced-by-count":56,"title":["Amyloidosis"],"prefix":"10.1093","volume":"77","author":[{"given":"M F","family":"Khan","sequence":"first","affiliation":[{"name":"Amyloidosis Treatment and Research Center, Boston University School of Medicine , 715 Albany Street, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R H","family":"Falk","sequence":"additional","affiliation":[{"name":"Amyloidosis Treatment and Research Center, Boston University School of Medicine , 715 Albany Street, Boston, MA 02118, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,11,1]]},"reference":[{"key":"2023042613440812900_B1","first-page":"103","article-title":"Cases of lardaceous disease and some allied affections, with remarks.","volume":"2","author":"Wilks","year":"1856","journal-title":"Guy's Hosp Rep"},{"key":"2023042613440812900_B2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.1992.tb00625.x","article-title":"History of amyloidosis.","volume":"232","author":"Cohen","year":"1992","journal-title":"J Intern Med"},{"key":"2023042613440812900_B3","first-page":"1537","article-title":"Eine spezifische Amyloidfarbung mit Kongorot.","volume":"69","author":"Bennhold","year":"1922","journal-title":"Munch Med Wochenschr"},{"key":"2023042613440812900_B4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/1831202a0","article-title":"Electron microscopic observations on a fibrous component in amyloid of diverse origins.","volume":"183","author":"Cohen","year":"1959","journal-title":"Nature"},{"key":"2023042613440812900_B5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1083\/jcb.33.3.679","article-title":"High-resolution electron microscopic analysis of the amyloid fibril.","volume":"33","author":"Shirahama","year":"1967","journal-title":"J Cell Biol"},{"key":"2023042613440812900_B6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3181\/00379727-131-34110","article-title":"Characterization of the amyloid fibril as a cross-beta protein.","volume":"131","author":"Bonar","year":"1969","journal-title":"Proc Soc Exp Biol Med"},{"key":"2023042613440812900_B7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.167.3.903","article-title":"Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.","volume":"167","author":"Hawkins","year":"1988","journal-title":"J Exp Med"},{"key":"2023042613440812900_B8","first-page":"139","article-title":"Further characterization of amyloid-enhancing factor.","volume":"47","author":"Axelrad","year":"1982","journal-title":"Lab Invest"},{"key":"2023042613440812900_B9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2796.1992.tb00628.x","article-title":"Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition.","volume":"232","author":"Kisilevsky","year":"1992","journal-title":"J Intern Med"},{"key":"2023042613440812900_B10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/03009748009098131","article-title":"A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.","volume":"9","author":"Husby","year":"1980","journal-title":"Scand J Rheumatol"},{"key":"2023042613440812900_B11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses.","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.172.3988.1150","article-title":"Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.","volume":"172","author":"Glenner","year":"1971","journal-title":"Science"},{"key":"2023042613440812900_B13","first-page":"107","article-title":"The systemic amyloidoses: an overview.","volume":"45","author":"Falk","year":"2000","journal-title":"Adv Intern Med"},{"key":"2023042613440812900_B14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V68.1.220.220","article-title":"Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases.","volume":"68","author":"Kyle","year":"1986","journal-title":"Blood"},{"key":"2023042613440812900_B15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(71)80506-9","article-title":"The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences.","volume":"19","author":"Benditt","year":"1971","journal-title":"FEBS Lett"},{"key":"2023042613440812900_B16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2796.1992.tb00627.x","article-title":"Protein AA\/SAA.","volume":"232","author":"Skinner","year":"1992","journal-title":"J Intern Med"},{"key":"2023042613440812900_B17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-291X(05)80107-X","article-title":"The N-terminal segment of protein AA determines its fibrillogenic property.","volume":"182","author":"Westermark","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"2023042613440812900_B18","first-page":"37","article-title":"Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.","volume":"53","author":"Snow","year":"1985","journal-title":"Lab Invest"},{"key":"2023042613440812900_B19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.1780360616","article-title":"Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.","volume":"36","author":"Hawkins","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2023042613440812900_B20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: response and survival in 64 patients.","volume":"70","author":"Gertz","year":"1991","journal-title":"Medicine"},{"key":"2023042613440812900_B21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0006-291X(88)80909-4","article-title":"Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.","volume":"156","author":"Nichols","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2023042613440812900_B22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ng0393-252","article-title":"Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.","volume":"3","author":"Benson","year":"1993","journal-title":"Nat Genet"},{"key":"2023042613440812900_B23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-5793(90)80510-P","article-title":"Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene.","volume":"276","author":"Maury","year":"1990","journal-title":"FEBS Letters"},{"key":"2023042613440812900_B24","first-page":"44","article-title":"Transthyretin amyloidosis.","volume":"3","author":"Benson","year":"1996","journal-title":"Amyloid-International Journal of Experimental & Clinical Investigation"},{"key":"2023042613440812900_B25","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1073\/pnas.75.9.4499","article-title":"Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.","volume":"75","author":"Costa","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023042613440812900_B26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI112573","article-title":"Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis.","volume":"78","author":"Wallace","year":"1986","journal-title":"J Clin Invest"},{"key":"2023042613440812900_B27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s004390050199","article-title":"Revised transthyretin Ile 122 allele frequency in African-Americans.","volume":"98","author":"Jacobson","year":"1996","journal-title":"Hum Genet"},{"key":"2023042613440812900_B29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0006-291X(85)91948-5","article-title":"A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.","volume":"129","author":"Gejyo","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"2023042613440812900_B30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"2023042613440812900_B31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzeimer's disease is increased in vivio by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"2023042613440812900_B32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00045415-199711000-00010","article-title":"Cardiac amyloidosis.","volume":"5","author":"Reisinger","year":"1997","journal-title":"Cardiology in Review"},{"key":"2023042613440812900_B33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/path.1711650307","article-title":"Atrial amyloid deposits in the failing human heart display both atrial and brain natriuretic peptide-like immunoreactivity.","volume":"165","author":"Pucci","year":"1991","journal-title":"J Pathol"},{"key":"2023042613440812900_B34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM198709173171205","article-title":"Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.","volume":"317","author":"Olson","year":"1987","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9149(97)89403-9","article-title":"Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis.","volume":"77","author":"Dubrey","year":"1996","journal-title":"Am J Cardiol"},{"key":"2023042613440812900_B36","first-page":"4159","volume-title":"The metabolic and molecular bases of inherited disease.","author":"Benson","year":"1995","edition":"7th Ed."},{"key":"2023042613440812900_B37","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases.","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"2023042613440812900_B38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.67.6.819","article-title":"Pupil abnormality in amyloidosis with autonomic neuropathy.","volume":"67","author":"Davies","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042613440812900_B39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gut.42.5.727","article-title":"The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.","volume":"42","author":"Lovat","year":"1998","journal-title":"Gut"},{"key":"2023042613440812900_B40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archderm.1981.01650120061028","article-title":"Alopecia universalis. A manifestation of occult amyloidosis and multiple myeloma.","volume":"117","author":"Wheeler","year":"1981","journal-title":"Arch Dermatol"},{"key":"2023042613440812900_B41","first-page":"110","article-title":"Reduced taste perception in AL amyloidosis. A frequently unnoticed sensory impairment.","volume":"81","author":"Marinone","year":"1996","journal-title":"Haematologica"},{"key":"2023042613440812900_B42","first-page":"310","volume-title":"Harrison's principles of internal medicine.","author":"Bolognia","year":"1998","edition":"14th Ed."},{"key":"2023042613440812900_B43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM197707142970203","article-title":"Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X.","volume":"297","author":"Furie","year":"1977","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement.","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2023042613440812900_B45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.","volume":"13","author":"Klein","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2023042613440812900_B46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01254559","article-title":"Imaging amyloidosis with radiolabelled SAP.","volume":"22","author":"Hawkins","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"2023042613440812900_B47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","article-title":"Clinical improvement and amyloid regression after amyloid transplantation in hereditary transthyretin amyloidosis.","volume":"341","author":"Holmgren","year":"1993","journal-title":"Lancet"},{"key":"2023042613440812900_B48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2796.1992.tb00630.x","article-title":"Amyloid P component and the diagnosis of amyloidosis.","volume":"232","author":"Pepys","year":"1992","journal-title":"J Intern Med"},{"key":"2023042613440812900_B49","first-page":"365","article-title":"Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.","volume":"86","author":"Hawkins","year":"1993","journal-title":"Q J Med"},{"key":"2023042613440812900_B50","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archinte.1983.00350080055015","article-title":"Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis.","volume":"143","author":"Libbey","year":"1983","journal-title":"Arch Intern Med"},{"key":"2023042613440812900_B51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(87)90439-6","article-title":"Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years' experience.","volume":"82","author":"Duston","year":"1987","journal-title":"Am J Med"},{"key":"2023042613440812900_B52","first-page":"157","article-title":"Light and electron microscopy immunohistochemical characterization of amyloid deposits.","volume":"4","author":"Arbustini","year":"1997","journal-title":"Amyloid-International Journal of Experimental & Clinical Investigation"},{"key":"2023042613440812900_B53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/elps.1150071110","article-title":"Seperation of hybrid isoelectric fousing of normal human plasma transthyretin (prealbumin) and a variant with a methionine for valine substitution associated with familial amyloidotic polyneuropathy.","volume":"7","author":"Altland","year":"1986","journal-title":"Electrophoresis"},{"key":"2023042613440812900_B54","first-page":"277","volume-title":"Advances in immunohistochemistry.","author":"Shirahama","year":"1984"},{"key":"2023042613440812900_B55","first-page":"60","article-title":"Treatment of primary amyloidosis.","volume":"32","author":"Merlini","year":"1995","journal-title":"Semin Hematol"},{"key":"2023042613440812900_B56","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"2023042613440812900_B57","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy.","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"2023042613440812900_B58","first-page":"235","volume-title":"Current therapy in allergy, immunology, and rheumatology.","author":"Skinner","year":"1996"},{"key":"2023042613440812900_B59","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine versus placebo in neurogenic orthostatic hypotension: a randomised, double-blind multicenter study.","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"2023042613440812900_B60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199308263290904","article-title":"Treatment of orthostatic hypotension with erythropoietin.","volume":"329","author":"Hoeldtke","year":"1993","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B61","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0002-9343(87)90222-1","article-title":"Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973).","volume":"82","author":"Cohen","year":"1987","journal-title":"Am J Med"},{"key":"2023042613440812900_B62","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9343(85)90521-2","article-title":"Primary systemic amyloidosis. Comparison of melphalan\/prednisone versus colchicine.","volume":"79","author":"Kyle","year":"1985","journal-title":"Am J Med"},{"key":"2023042613440812900_B63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"2023042613440812900_B64","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B65","first-page":"12","article-title":"Intensive chemotherapy for AL amyloidosis.","volume":"35","author":"Persey","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2023042613440812900_B66","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1182\/blood.V88.7.2801.bloodjournal8872801","article-title":"Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients.","volume":"88","author":"Comenzo","year":"1996","journal-title":"Blood"},{"key":"2023042613440812900_B67","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"2023042613440812900_B68","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1073\/pnas.92.7.2959","article-title":"Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.","volume":"92","author":"Merlini","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023042613440812900_B69","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood.V93.3.1112","article-title":"Treatment of AL amyloidosis with 4\u2032-iodo-4\u2032-deoxydoxorubicin: an update.","volume":"93","author":"Merlini","year":"1999","journal-title":"Blood"},{"key":"2023042613440812900_B70","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bmj.309.6962.1135","article-title":"Cardiac transplantation for AL amyloidosis.","volume":"309","author":"Hall","year":"1994","journal-title":"BMJ"},{"key":"2023042613440812900_B71","first-page":"284","article-title":"Heart transplantation in AL amyloidosis.","volume":"2","author":"Dubrey","year":"1995","journal-title":"Amyloid-International Journal of Experimental & Clinical Investigation"},{"key":"2023042613440812900_B72","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma.","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B73","first-page":"314a","article-title":"Therapy with TNF-r Enbrel\u00ae results in remarkable symptom relief in patients (pts) with advanced primary amyloidosis (AL) [abstract].","volume":"94 (suppl 1)","author":"Juturi","year":"1999","journal-title":"Blood"},{"key":"2023042613440812900_B74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0004.1991.tb03085.x","article-title":"Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30).","volume":"40","author":"Holmgren","year":"1991","journal-title":"Clin Genet"},{"key":"2023042613440812900_B75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-120-2-199401150-00006","article-title":"Liver transplantation as a treatment for familial amyloidotic polyneuropathy.","volume":"120","author":"Skinner","year":"1994","journal-title":"Ann Intern Med"},{"key":"2023042613440812900_B76","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1072-7515(99)00208-2","article-title":"Domino liver transplants for metabolic disorders: experiance with familial amyloidotic polyneuropathy.","volume":"189","author":"Azoulay","year":"1999","journal-title":"J Am Coll Surg"},{"key":"2023042613440812900_B77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0168-8278(99)80076-2","article-title":"Familial amyloidotic polyneuropathy: domino liver transplantation.","volume":"30","author":"Schmidt","year":"1999","journal-title":"J Hepatol"},{"key":"2023042613440812900_B78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0041-1345(98)01733-3","article-title":"Domino liver transplantation for familial amyloid polyneuropathy: optimal use of a scarce resource.","volume":"31","author":"Hemming","year":"1999","journal-title":"Transplant Proc"},{"key":"2023042613440812900_B79","first-page":"479","article-title":"On the formation and disappearance of amyloid in man.","volume":"63","author":"Waldenstrom","year":"1928","journal-title":"Acta Chir Scand"},{"key":"2023042613440812900_B80","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-87-5-568","article-title":"Prolonged colchicine treatment in four patients with amyloidosis.","volume":"87","author":"Ravid","year":"1977","journal-title":"Ann Intern Med"},{"key":"2023042613440812900_B81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"key":"2023042613440812900_B82","first-page":"73","article-title":"Amyloidosis in juvenile chronic arthritis.","volume":"9","author":"David","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"2023042613440812900_B83","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ki.1992.207","article-title":"Dialysis-related amyloidosis.","volume":"41","author":"Koch","year":"1992","journal-title":"Kidney Int"},{"key":"2023042613440812900_B84","first-page":"369","article-title":"Does dialysis-associated amyloidosis resolve after transplantation?","volume":"8","author":"Nelson","year":"1993","journal-title":"Nephrol Dial Transplant"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/77\/913\/686\/50043235\/postgradmedj-77-686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/77\/913\/686\/50043235\/postgradmedj-77-686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T13:53:32Z","timestamp":1682517212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/77\/913\/686\/7039436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":84,"journal-issue":{"issue":"913","published-online":{"date-parts":[[2001,11,1]]},"published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.77.913.686","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,11]]},"published":{"date-parts":[[2001,11,1]]}}}